Navigation Links
Targeted Anesthesia Can Minimize Pain During Prostate Biopsy

According to the latest study by the Mayo clinic, injecting an anesthetic at certain points can reduce the pain during prostate biopsy.//

The new study that is being presented today at the annual meeting of the North Central Section of the American Urological Association, in San Diego, had found that about 16% of patients encounter a moderate or higher level of pain during their biopsy. It was explained that the biopsies are commonly performed on men who have had abnormal digital rectal exams or elevated prostate-specific antigen (PSA) tests, both of which seek prostate cancer.

The researchers explained that for this study they had engaged 243 men who were on schedule for undertaking a prostate biopsy. They were assigned to receive an anesthetic for the relief of pain at one among the three locations.

Richard Ashley, Mayo Clinic urology resident and lead study investigator, said, “Prostate biopsy evokes significant anxiety for some men due to anticipated pain associated with the procedure.” He also added, “Patients should request that anesthetic be used at the time of a biopsy, and pain control should be the standard of care in a urologist's office.”


IK
'"/>




Page: 1

Related medicine news :

1. Gel Offers A More Targeted Approach
2. New Vaccine Targeted At Effective Treatment Against Tuberculosis
3. Doctors, Pharma Companies Targeted By CBI Raids
4. Treatment Resistant Tumors Can Be Targeted Better Using Botox
5. KFC Targeted in Lawsuit
6. Now, Silica Nanobubbles for Targeted Drug Delivery
7. Targeted Compound Helps Recurrent Prostate Cancer Patients
8. Tumors Targeted Naturally
9. New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs
10. Bypass Heart Surgery Performed Without General Anesthesia
11. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint ... option for on-premises installation of its Help System for SharePoint was at the farm ... into the entire tenant. , The company recently released a modified version of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual ... the Diabetes Risk Test to find out if they are at risk for developing ... light up the evening sky by programming the LAX pylons the color red. Downtown’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... to be invited to the Siemens Healthineers annual customer education symposium, a world-class ... will take place from March 27 - 31, 2017 at the Atlanta Marriott ...
(Date:3/28/2017)... ... March 29, 2017 , ... ... pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March ... common questions regarding thyroid function. , Dr. Izabella Wentz is a licensed ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets ... Treated at Proton Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in ... from its market value in 2016. There are currently three proton therapy ... capacity to treat more patients. In Italy , the ...
(Date:3/29/2017)... 29, 2017  Providence Medical Technology, Inc., an ... of two industry veterans to the commercial leadership ... company to lead Global Marketing, and Michael ... Lynch and Mr. Scott have over 40 years ... Lynch joins the company with over 22 years ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
Breaking Medicine Technology: